Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CC chemokine receptor 2 is involved in intestinal homing of alloreactive donor CD8(+) T cells during GVHD
    Meeting Abstract

    Terwey, T. H.; Kochman, A. A.; Eng, J. M.; Hubbard, V. M.; Muriglan, S. J.; Waldman, E. D.; Zakrzewski, J. L.; Alpdogan, O.; van den Brink, M. R. M.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Pokemon protein characterization and expression in B and T-cell lymphomas
    Meeting Abstract

    Teruya-Feldstein, J.; Maeda, T.; Hobbs, R.; Merghoub, T.; Guernah, I.; Zelenent, A.; Pandolfi, P.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • Pokemon protein characterization and expression in B and T-cell lymphomas
    Meeting Abstract

    Teruya-Feldstein, J.; Maeda, T.; Hobbs, R.; Merghoub, T.; Guernah, I.; Zelenent, A.; Pandolfi, P.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Implications of ductal carcinoma in situ in predicting BRCA status in Ashkenazi Jewish women
    Meeting Abstract

    Sukumvanich, P.; Wadsworth, E.; Nafa, K.; Kolachana, P.; Borgen, P. I.; Robson, M. E.; Offit, K.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • Concurrent cetuximab, cisplatin, and radiotherapy (RT) for loco-regionally advanced squamous cell carcinoma of the head and neck (SCCHN): Updated results of a novel combined modality paradigm
    Meeting Abstract

    Su, Y. B.; Kraus, D. H.; Zelefsky, M. J.; Lis, E.; Nolden, S. L.; Herman, K.; Sedarati, F.; Shaha, A. R.; Shah, J. P.; Pfister, D. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The clinical significance of a PSA nadir > 0.2 to patients with a rising post-operative or post-radiation PSA treated with androgen deprivation
    Meeting Abstract

    Stewart, A. J.; Scher, H.; Chen, M. H.; McLeod, D.; Carroll, P.; Moul, J.; D'Amico, A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Paclitaxel and carboplatin (TP) for treatment of advanced or recurrent endometrial cancer: A retrospective study
    Meeting Abstract

    Sovak, M. A.; Chuai, S.; Anderson, S.; Barakat, R.; Dupont, J.; Hensley, M. L.; Sabbatini, P.; Spriggs, D. R.; Aghajanian, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • FLT PET as a non-invasive marker of response to MEK inhibition
    Meeting Abstract

    Solit, D. B.; Santos, E.; Pratilas, C.; Moroz, M.; Blasberg, R.; Sebolt-Leopold, J.; Larson, S. M.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Inhibitors of Hsp90 induce the degradation of HER2 and inhibit the growth of HER2-dependent breast tumors
    Meeting Abstract

    Solit, D. B.; Basso, A.; Smith-Jones, P.; Modi, S.; Norton, L.; Larson, S.; Neckers, L.; Scher, H.; Hudis, C.; Rosen, N.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save